A detailed history of Summit Trail Advisors, LLC transactions in Icad Inc stock. As of the latest transaction made, Summit Trail Advisors, LLC holds 75,000 shares of ICAD stock, worth $282,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
75,000
Previous 117,000 35.9%
Holding current value
$282,750
Previous $214,000 28.04%
% of portfolio
0.01%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 28, 2025

SELL
$1.87 - $3.69 $78,540 - $154,980
-42,000 Reduced 35.9%
75,000 $154,000
Q4 2024

Jan 29, 2025

BUY
$1.39 - $2.4 $162,630 - $280,800
117,000 New
117,000 $214,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $95.5M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Summit Trail Advisors, LLC Portfolio

Follow Summit Trail Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Summit Trail Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Summit Trail Advisors, LLC with notifications on news.